Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × bemcentinib × Clear all

Phase

Status

Completed 5 Terminated 3 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 1

Interventions

Cisplatin 459 Radiotherapy 335 Cyclophosphamide 319 Carboplatin 315 Paclitaxel 296 Capecitabine 294 Oxaliplatin 288 Docetaxel 275 Gemcitabine 273 Fluorouracil 249 apatinib 227 Drug Therapy 227 Bevacizumab 207 camrelizumab 188 Etoposide 176 Irinotecan 160 Doxorubicin 155 Leucovorin 136 Dexamethasone 136 Cytarabine 130 Blood Specimen Collection 130 pembrolizumab 123 Neoadjuvant Therapy 122 sintilimab 117 Pemetrexed 117 anlotinib 115 Rituximab 112 toripalimab 111 S 1 (combination) 111 Surgical Procedures, Operative 109

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03654833 2023-03-14

MiST

University of Leicester

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡